en

PRODUCT DETAIL

M-M-RVAXPRO prášok a disperzné prostredie na injekčnú suspenziu v naplnenej injekčnej striekačke

Code 36425
MA number EU/1/06/337/013
Product Form: plv sul 20x liek.+20x solv. (skl.liek.+napl.skl.striek.s 2 samost.ihlami)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Merck Sharp & Dohme B.V., Netherland
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J07 VACCINES
J07B VIRAL VACCINES
J07BD Measles vaccines (old: Morbilli vaccines)
J07BD52 Measles, co. w. mumps a. rubella, l. att. (old: Morbilli, co. w. parotit. a. rub., li. att.)
Shelf life: 24
Container: glass container
Route of admin.: Subcutaneous and intramuscular use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application
MA issued: 05.05.2006
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 20.04.2022
eu-flag.png sk-flag.png